Clinical Trial Update: LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus [NA]

View source ↗

Summary

The LUPUS-BEST trial evaluating a treat-to-target strategy in systemic lupus erythematosus is currently recruiting at Heinrich-Heine University in Düsseldorf.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Systemic Lupus Erythematosus | NA | Status: RECRUITING